Integer Holdings (ITGR) Cash from Operations Growth (1y) (2011 - 2026)
Integer Holdings (ITGR) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -12.60% |
| 10 | Integer Holdings | 4.26 Bn | 4.24 Bn | 112.94 Mn | 36.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 36.19% |
| Apr 3, 2026 | -21.04% |
| Dec 31, 2025 | -12.36% |
| Sep 26, 2025 | -8.26% |
| Jun 27, 2025 | -7.14% |
| Mar 28, 2025 | 34.58% |
| Dec 31, 2024 | 13.75% |
| Sep 27, 2024 | 14.78% |
| Jun 28, 2024 | -15.87% |
| Mar 29, 2024 | 275.55% |
| Dec 31, 2023 | 7.72% |
| Sep 29, 2023 | 124.33% |
| Jun 30, 2023 | 197.85% |
| Mar 31, 2023 | -65.93% |
| Dec 31, 2022 | 31.45% |
| Sep 30, 2022 | -42.89% |
| Jul 1, 2022 | -41.75% |
| Apr 1, 2022 | -50.15% |
| Dec 31, 2021 | -44.79% |
| Oct 1, 2021 | 50.61% |